X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NGM

Closed

Ngm Biopharmaceuticals Inc

1.54
0.00 (0.00%)
Last Update: 08 Apr 2024 16:30:00
Yesterday: 1.54
Day's Range: 1.54 - 1.54
Send
When Written:
 
3.83
NGM Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops and commercializes transformative therapeutics for patients with unmet medical needs. The company's pipeline includes multiple product candidates designed to address a range of diseases, including liver and metabolic diseases, retinal diseases, cancer, and inflammatory conditions. NGM's lead product candidate, NGM282, is a potential treatment for nonalcoholic steatohepatitis (NASH), a chronic liver disease that affects millions of people worldwide. The company was founded in 2008 and is headquartered in South San Francisco, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X